Predictive performance of physiologically based kinetic (PBK) models based on in-silico/in vitro-in vivo extrapolation (IS/IVIVE)

被引:0
|
作者
Kalra, P. [1 ]
Zhou, H. [1 ]
Lawless, M. [1 ]
机构
[1] Simulat Plus, Lancaster, PA USA
关键词
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
P22-40
引用
收藏
页码:S259 / S260
页数:2
相关论文
共 50 条
  • [21] Development of physiologically based pharmacokinetic (PBPK) models for quantitative in vitro-in vivo extrapolations (QIVIVE)
    Punt, A.
    TOXICOLOGY LETTERS, 2022, 368 : S5 - S5
  • [22] Strategies to evaluate in vitro in silico physiologically based kinetic (PBK) models as essential tool in next generation (animal-free) risk evaluations
    Punt, A.
    Beekmann, K.
    Fabian, E.
    van Ravenzwaay, B.
    Carmichael, P. L.
    Sorrell, I.
    Moxon, T. E.
    TOXICOLOGY LETTERS, 2021, 350 : S46 - S46
  • [23] Refinement of in vitro to in vivo extrapolation (IVIVE) of potential endocrine disruptors based on in vitro dosimetry approaches
    Dimitrijevic, D.
    Fabian, E.
    Gomes, C.
    Funk-Weyer, D.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S67 - S67
  • [24] Species Extrapolation of Life-Stage Physiologically-Based Pharmacokinetic (PBPK) Models to Investigate the Developmental Toxicology of Ethanol Using In vitro to In vivo (IVIVE) Methods
    Martin, Sheppard A.
    McLanahan, Eva D.
    Bushnell, Philip J.
    Hunter, E. Sidney, III
    El-Masri, Hisham
    TOXICOLOGICAL SCIENCES, 2015, 143 (02) : 512 - 535
  • [25] Physiologically-Based Kinetic (PBK) Models and Applications In Read-Across
    Madden, J.
    Thompson, C.
    Webb, S.
    Penson, P.
    Tan, C.
    Paini, A.
    TOXICOLOGY LETTERS, 2023, 384 : S32 - S33
  • [26] CYP2B6 Pharmacogenetics-Based In Vitro-In Vivo Extrapolation of Efavirenz Clearance by Physiologically Based Pharmacokinetic Modeling
    Xu, Cong
    Quinney, Sara K.
    Guo, Yingying
    Hall, Stephen D.
    Li, Lang
    Desta, Zeruesenay
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2004 - 2011
  • [27] Impact of In Vitro Experimental Variation in Kinetic Parameters on Physiologically Based Kinetic (PBK) Model Simulations
    Punt, Ans
    Bos, Peter
    Hakkert, Betty
    Louisse, Jochem
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2023, 40 (02) : 237 - 247
  • [28] In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
    Yukiko Murata
    Sibylle Neuhoff
    Amin Rostami-Hodjegan
    Hiroyuki Takita
    Zubida M. Al-Majdoub
    Kayode Ogungbenro
    The AAPS Journal, 24
  • [29] In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition
    Murata, Yukiko
    Neuhoff, Sibylle
    Rostami-Hodjegan, Amin
    Takita, Hiroyuki
    Al-Majdoub, Zubida M.
    Ogungbenro, Kayode
    AAPS JOURNAL, 2022, 24 (01):
  • [30] Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols
    Marije Strikwold
    Bert Spenkelink
    Laura H. J. de Haan
    Ruud A. Woutersen
    Ans Punt
    Ivonne M. C. M. Rietjens
    Archives of Toxicology, 2017, 91 : 2119 - 2133